Influence of Age on Guideline-Concordant Cancer Care for Elderly Patients in the United States

Purpose To examine the frequency of guideline-concordant cancer care in elderly patients, including “older” elderly (age ≥80 years). Methods and Materials Using the Surveillance, Epidemiology and End Results–Medicare dataset in patients aged ≥66 years diagnosed with nonmetastatic breast cancer (n=55...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of radiation oncology, biology, physics biology, physics, 2017-07, Vol.98 (4), p.748-757
Hauptverfasser: Fang, Penny, MD, He, Weiguo, PhD, Gomez, Daniel R., MD, Hoffman, Karen E., MD, MPH, Smith, Benjamin D., MD, Giordano, Sharon H., MD, MPH, Jagsi, Reshma, MD, DPhil, Smith, Grace L., MD, PhD, MPH
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Purpose To examine the frequency of guideline-concordant cancer care in elderly patients, including “older” elderly (age ≥80 years). Methods and Materials Using the Surveillance, Epidemiology and End Results–Medicare dataset in patients aged ≥66 years diagnosed with nonmetastatic breast cancer (n=55,094), non–small cell lung (NSCLC) (n=36,203), or prostate cancer (n=86,544) from 2006 to 2011, chemotherapy, surgery, and radiation (RT) treatments were identified using claims. Pearson χ2 tested associations between age and guideline concordance. Results Older patients were less likely to receive guideline-concordant curative treatment: in stage III breast cancer, receipt of postmastectomy RT (70%, 46%, and 21% in patients aged 66-79, 80-89, and ≥90 years, respectively; P
ISSN:0360-3016
1879-355X
DOI:10.1016/j.ijrobp.2017.01.228